Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16864098 | 0.86 | CYP3A4 (0.31) | CYP3A4CYP2D6HIF1A | |
| SCHEMBL14769061 | 0.83 | MEN1 (0.31) | — | |
| SCHEMBL16154220 | 0.82 | CYP3A4 (0.40) | CYP3A4CYP2D6HIF1A | |
| SCHEMBL14726006 | 0.81 | HRH3 (0.32) | CYP3A4CYP2D6HIF1A | |
| SCHEMBL112090 | 0.81 | MEN1 (0.36) | CYP3A4CYP2D6HIF1A | |
| SCHEMBL16692368 | 0.79 | MEN1 (0.35) | CYP3A4CYP2D6HIF1A | |
| SCHEMBL111024 | 0.76 | CYP3A4 (0.36) | CYP3A4CYP2D6HIF1A | |
| SCHEMBL22489571 | 0.75 | CYP3A4 (0.34) | CYP3A4CYP2D6HIF1A | |
| SCHEMBL111166 | 0.75 | HTR1A (0.35) | CYP3A4CYP2D6HIF1A | |
| SCHEMBL21160851 | 0.75 | CYP2D6 (0.33) | CYP3A4CYP2D6HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9068050-B2 | Bridged bis(alkoxysilane) or silsesquioxane compound having benzoxazine-containing group | Chung-Shan Institute of Science and Technology, Armaments, Bureau, Ministry of National Defense (TW) | 2015-06-30 | — | — | US | disclosed |
| US-20130053529-A1 | Bridged Bis(Alkoxysilane) or Silsesquioxane Compound Having Benzoxazine-Containing Group | Chung-Shan Institute of Science and Technology, Armaments, Bureau, Ministry of National Defense (TW) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053529-A1 | Bridged Bis(Alkoxysilane) or Silsesquioxane Compound Having Benzoxazine-Containing Group | YBX1, EPCAM, LATS1 | CYP3A4 3001/4885CYP2D6 4410/4885HIF1A 723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.